|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries
521 Cottonwood Drive Suite 111
Milpitas
United States of America, California
Toll free: 1-866- 497-4180
Phone: 1-408-773-8007
Fax: 1-408-773-8238
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: N/A
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell models as tools for drug discovery and therapeutics, bioproduction. (1) An advanced series of services and products in stem cell technologies (iPSC/ ESCs, patient/ genome edited lines, differentiated cells, genome edited lines) to build patient relevant cell line models for allogenic banking, disease modeling, drug screening, personalized medicine, regenerative medicine, and tissue engineering. Learn more about our iPSC derived immune cells, GMP iPSC, and allognic universal iPSC approach. (2) In vivo model generation (humanized and conditional/inducible expression mouse models) to build physiologically predictive models; and model validation and drug discovery/screening (antibody, vaccines, gene/cell therapy) using in vivo-based assays such as proof-of-concept studies, dose ranging, biodistribution, toxicity assessments for your early stage drug candidates. Access our mouse repositary, more than 2000 off-the-shelf mouse models, includes PD-1, PD-L1 for antibody efficacy studies. (3) Innovative mammalian cell gene expression technology, TARGATT™ to build large cell-based screening libraries for protein evolution, antibody discovery and screening, and bioproduction/ bioprocessing. Platform includes HEK293, CHO and rabbit monoclonal antibody generation. (4) A comprehensive BioService CRO platform offering custom solutions for early-stage cell and gene therapy projects by leveraging our genome editing and stem cell technology expertise: PBMC procurement, AAV serotype selection, gene therapy construct design and optimization, assay development (AAV potency assays, efficacy validation, and toxicology studie); and, consultation for cell-banking, pre-IND filing and CMC processes.
Selected Categories:
Last update of this entry: September 28, 2021
|